These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10254882)

  • 1. The P&T Committee and cancer chemotherapy: Part II. Who should prescribe anticancer drugs.
    Krakoff IH
    Hosp Formul; 1982 Apr; 17(4):577-8. PubMed ID: 10254882
    [No Abstract]   [Full Text] [Related]  

  • 2. Editors' roundtable: current formulas for P & T Committee success. (Part 2).
    Lipman AG; Neu HC; Singh BN; Weintraub M
    Hosp Formul; 1987 Apr; 22(4):373-82. PubMed ID: 10281367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug utilization reviews--a major responsibility of the P&T committee: an administrative overview.
    Godwin HN
    Hosp Formul; 1981 Jun; 16(6):609, 613-5. PubMed ID: 10251441
    [No Abstract]   [Full Text] [Related]  

  • 4. The P&T committee and drug use review.
    Provost GP
    Hosp Formul; 1979 May; 14(5):596, 594. PubMed ID: 10242199
    [No Abstract]   [Full Text] [Related]  

  • 5. Making your P & T Committee work for you.
    Lipman AG
    Hosp Formul; 1987 Jan; 22(1):103-4. PubMed ID: 10311841
    [No Abstract]   [Full Text] [Related]  

  • 6. Survey of P&T committee members: glaucoma agents gaining notice.
    Manag Care; 2002 Nov; 11(11 Suppl):58-60. PubMed ID: 15357541
    [No Abstract]   [Full Text] [Related]  

  • 7. Editors' roundtable: Current formulas for P & T Committee success (Part 1).
    Lipman AG; Neu HC; Singh BN; Weintraub M
    Hosp Formul; 1987 Mar; 22(3):288-98. PubMed ID: 10312015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ASHP statement on the pharmacy and therapeutics committee.
    Am J Hosp Pharm; 1978 Jul; 35(7):813-4. PubMed ID: 665701
    [No Abstract]   [Full Text] [Related]  

  • 9. ASHP statement on the pharmacy and therapeutics committee.
    Am J Hosp Pharm; 1992 Aug; 49(8):2008-9. PubMed ID: 1442847
    [No Abstract]   [Full Text] [Related]  

  • 10. [Analysis of the selection process for new drugs in a tertiary hospital 2004-2007].
    Alfaro-Lara ER; Galván-Banqueri M; Prado-Mel E; Santos-Ramos B; Varela-Aguilar JM; Torelló-Iserte J; Castellano Zurera MM; Bautista Paloma FJ
    Farm Hosp; 2010; 34(2):76-84. PubMed ID: 20304366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulary management at a tertiary-care facility: P&T committee interview.
    Lucas RV; Abramowitz PW
    Hosp Formul; 1988 Feb; 23(2):162-8, 172-3. PubMed ID: 10286021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug usage guidelines, Part 3: assessment of acceptance of the program.
    Patry RA; Huber SL; Rice G; Hudson HD; Godwin HN
    Hosp Formul; 1985 Apr; 20(4):464, 470-4. PubMed ID: 10270728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anticancer drugs off label used of: what do the experts think about?].
    Debrix I; André T; Becker A; Lotz JP; Gligorov J; Boukari Y; Milleron B; Pene F; Flahault A
    Bull Cancer; 2004 Oct; 91(10):769-77. PubMed ID: 15556877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P & T Committee interview: Promoting rational drug use.
    Hunt TK; Herfindal ET
    Hosp Formul; 1988 Apr; 23(4):359-62, 365-6, 369. PubMed ID: 10286839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing an effective P & T Committee, Part 2.
    Abramowitz PW; Godwin HN; Latiolais CJ; McDougal TR; Miller WA; Ravin RL
    Hosp Formul; 1985 Oct; 20(10):1071-2, 1078-81, 1086 passim. PubMed ID: 10273830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P&T Committee antibiotic cost considerations.
    Rinehart JR
    Hosp Formul; 1986 Aug; 21(8):857-9, 862-4. PubMed ID: 10277580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does your committee pass the McNemar test?
    Owen JA
    Hosp Formul; 1979 Jun; 14(6):605. PubMed ID: 10242200
    [No Abstract]   [Full Text] [Related]  

  • 18. Adverse drug reactions and the P & T committee.
    Lipman AG
    Hosp Formul; 1980 Jul; 15(7):580. PubMed ID: 10247654
    [No Abstract]   [Full Text] [Related]  

  • 19. What guidelines should a P & T Committee consider for the handling of cytotoxic drugs?
    Mofenson HC; Caraccio TR
    Hosp Formul; 1988 Nov; 23(11):923-4. PubMed ID: 10290755
    [No Abstract]   [Full Text] [Related]  

  • 20. [Drug committees towards the regions. The Danish Society of Clinical Pharmacology].
    Reuther LØ; Brock B;
    Ugeskr Laeger; 2007 Mar; 169(12):1113. PubMed ID: 17394824
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.